EP News Bureau

Market authorisation covers 2 mg and 4 mg pen presentations in Canada

Where the future of Indian Pharma takes shape.

Symposium focuses on translating research into clinical application in ophthalmology

Therapy targets gram-negative bacterial infections in critical care settings

Appointment to focus on private equity and M&A advisory in life sciences sector

Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections

Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; market size at US$ 145 million

Former Cipla CEO to lead next phase for CDMO platform focused on complex chemistry and APIs

Five-year agreement focuses on open science access, joint research and capability building

Deal combines portfolios and expands presence across women’s health, biosimilars and global markets